Magnetar Financial’s Forte Biosciences FBRX Stock Holding History

Magnetar Financial’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-27	Closed	-$104K	–	645
2017 Q4	$104K	Buy	+27	New	+$108K	﹤0.01%	665

Other funds holding FBRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Magnetar Financial's FBRX Position: Q1 2018 in Review

Magnetar Financial sold out of Forte Biosciences (FBRX) in Q1 2018, closing a stake of 27 shares — an estimated $104K sold.

Magnetar Financial first reported a position in FBRX in Q4 2017 and held it in 1 quarter. The position peaked at $104K in Q4 2017. 58 funds tracked by Wall St. Rank hold FBRX as of Q1 2018.

Magnetar Financial reported no remaining Forte Biosciences position as of Q1 2018 after selling out during the quarter.
Magnetar Financial sold 27 Forte Biosciences shares in Q1 2018, an estimated $104K.
Magnetar Financial first reported a position in Forte Biosciences in Q4 2017 and held it in 1 quarter.
Magnetar Financial's Forte Biosciences position peaked at $104K in Q4 2017.
58 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2018.

Based on Magnetar Financial's 13F filing for Q1 2018, filed 15 May 2018.